Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: A review of adherence data

Journal of Neuroscience Nursing

Volumn 42, Issue SUPPL.5, 2010, Pages

  Caon, Christina ^a   Saunders, Carol ^b   Smrtka, Jennifer ^a   Baxter, Nancy ^b   Shoemaker, Jennifer ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ft Lauderdale MS Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

DRUG SELF ADMINISTRATION; HEALTH PROMOTION; HUMAN; MULTIPLE SCLEROSIS; NURSE ATTITUDE; NURSING; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENT DISEASE; REMISSION; REVIEW; SELF CONCEPT; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIRHEUMATIC AGENTS; HEALTH PROMOTION; HUMANS; INJECTIONS, SUBCUTANEOUS; MEDICATION ADHERENCE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NURSE'S ROLE; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; RECURRENCE; REMISSION INDUCTION; SELF ADMINISTRATION; SELF EFFICACY;

EID: 78651420069     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/JNN.0b013e3181ee1240     Document Type: Review

References (18)

1. Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review. 84(2), 191-215.
2. Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Upper Saddle River, NJ: Prentice Hall.
3. Berger, B. A., Hudmon, K. S., & Liang, H. (2004). Predicting treatment discontinuation among patients with multiple sclerosis: Application of the transtheoretical model of change. Journal of the American Pharmacists Association, 44(4), 445-454.
4. Bombardier, C. H., Cunniffe, M., Wadhwani, R., Gibbons, L. E., Blake, K. D., & Kraft, G. H. (2008). The efficacy of telephone counseling for health promotion in people with multiple sclerosis: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 89, 1849-1856.
5. Costello, K., Kennedy, P., & Scanzillo, J. (2008). Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape Journal of Medicine, 10(9), 225.
6. Devonshire, V., Lapierre, Y., MacDonell, R., Ramo Tello, C., Patti, F., Fontoura, P., et al. (2006). The Global Adherence Project-A multicentre observational study on adherence to disease-modifying therapies in patients suffering from relapsing-remitting multiple sclerosis. Multiple Sclerosis, 12(Suppl.), S82.
7. Fraser, C.,Margante, L., Hadjimichael, O., & Vollmer, T. (2004). A prospective study of adherence to glatiramer acetate in individuals with multiple sclerosis. Journal of Neuroscience Nursing, 36(3), 120-129.
8. Fraser, C., & Polito, S. (2007). A comparative study of selfefficacy in men and women with multiple sclerosis. Journal of Neuroscience Nursing, 39(2), 102-106.
9. Kennedy, P. (2007). Partnership between Shared Solutions® and SM office nurses: Adherence enhancement program. Presented at the 21st Annual Meeting of the Consortium of Multiple Sclerosis Centers, May 30-June 2, Washington, DC.
10. Mohr, D. C., Boudewyn, A. C., Likosky, W., Levine, E., & Goodkin, D. E. (2001). Injectable medication for the treatment of multiple sclerosis: The influence of selfefficacy expectations and injection anxiety on adherence and ability to self-inject. Annals of Behavioral Medicine, 23(2), 125-132.
11. Namey, M. A. (2007). Promoting adherence to complex protocols. In J. Halper (Ed.), Advanced concepts in multiple sclerosis nursing care (2nd ed., pp. 91-100). New York: Demos Medical Publishing.
12. Rigby, S. A., Domenech, E. W., Thornton, S., Tedman, S., & Young, C. A. (2003). Development and validation of a selfefficacy measure for people with multiple sclerosis: The Multiple Sclerosis Self-Efficacy Scale. Multiple Sclerosis 9, 73-81.
13. Río, J., Porcel, J., Téllez, N., Sánchez-Betancourt, A., Tintoré, M., Arévalo, M. J., et al. (2005). Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis. Multiple Sclerosis, 11(3), 306-309.
14. Ross, P. R. (2008). Tolerability, adherence, and patient outcomes. Neurology, 71(Suppl.), S1-S23.
15. Schapiro, R. T. (2004). Adherence to interferon beta-1b: BETA Nurse Program. International Journal of MS Care, 6, 66.
16. Treadway, K., Cutter, G., Salter, A., Lynch, S., Simsarian, J., Corboy, J., et al. (2009). Factors that influence adherence with disease-modifying therapy in MS. Journal of Neurology, 256, 568-576.
17. Turner, A. P., Kivlahan, D. R., Sloan, A. P., & Haselkorn, J. K. (2007). Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: Utility of the health beliefs model. Multiple Sclerosis, 13, 1146-1152.
18. Webb, U. H. (2008). Early interferon beta treatment in multiple sclerosis: Nursing care implications of the BENEFIT study. Journal of Neuroscience Nursing 40(6), 356-361.